Chelsea Kennedy

Chelsea Kennedy is a Senior Regulatory Operations Specialist at Emergent BioSolutions since September 2020, previously serving as a Regulatory Affairs Consultant. Prior experience includes role as Project Manager at HealthiVibe, a division of Corrona, LLC from September 2019 to March 2020, and as Global Regulatory Affairs Scheduler at Mylan from July 2015 to September 2019, where responsibilities included developing an electronic scheduling system for global eCTD submissions. Additionally, Chelsea worked as a Regulatory Affairs Associate, specializing in building and publishing eCTD global submissions. Chelsea holds a Bachelor of Arts in English Language and Literature from Southern New Hampshire University and an Associate of Science in Business Administration and Management from Pittsburgh Science and Technology Academy.